The invention is concerned with novel substituted benzimidazole derivatives of formula (I)
wherein R1 to R10 and X are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds bind to FXR and can be used as medicaments.
本发明涉及式(I)的新型取代
苯并咪唑衍
生物,其中R1至R10和X的定义如说明书和权利要求中所述,以及其生理上可接受的盐和酯。这些化合物与FXR结合,并可用作药物。